E-LIB Suche - Ergebnisse für: Tod, Michel

1

Therapeutic Drug Monitoring and Pharmacogenetic Testing as ..:

Cuvelier, Elodie ; Khazri, Houda ; Lecluse, Cloé...
Pharmaceuticals. 17 (2023) 1 - p. 21 , 2023

Link: https://doi.org/10.3390/..

2

Evaluation of Renal Impairment Influence on Metabolic Drug ..:

Tuloup, Vianney ; Goutelle, Sylvain ; Tod, Michel.
Clinical Pharmacokinetics. 62 (2023) 2 - p. 307-319 , 2023

Link: https://doi.org/10.1007/..

3

Considering the Oral Bioavailability of Protein Kinase Inhi..:

Le Louedec, Félicien ; Puisset, Florent ; Chatelut, Etienne.
Clinical Pharmacokinetics. 62 (2023) 1 - p. 55-66 , 2023

Link: https://doi.org/10.1007/..

4

A PK-PD model linking biomarker dynamics to progression-fre..:

Puszkiel, Alicja ; You, Benoit ; Payen, Léa...
Cancer Chemotherapy and Pharmacology. 91 (2023) 5 - p. 413-425 , 2023

Link: https://doi.org/10.1007/..

5

Clinical results of the EVESOR trial, a multiparameter phas..:

Varnier, Romain ; Puszkiel, Alicja ; Tod, Michel...
Cancer Chemotherapy and Pharmacology. 91 (2023) 5 - p. 361-373 , 2023

Link: https://doi.org/10.1007/..

6

Integrated multiple analytes and semi-mechanistic populatio..:

Pouzin, Clemence ; Gibiansky, Leonid ; Fagniez, Nathalie...
Journal of Pharmacokinetics and Pharmacodynamics. 49 (2022) 3 - p. 381-394 , 2022

Link: https://doi.org/10.1007/..

7

Modeled Early Longitudinal PSA Kinetics Prognostic Value in..:

Carrot, Aurore ; Elaidi, Reza-Thierry ; Colomban, Olivier...
Cancers. 14 (2022) 3 - p. 815 , 2022

Link: https://doi.org/10.3390/..

8

Low probability of disease cure in advanced ovarian carcino..:

You, Benoit ; Van Wagensveld, Lilian ; Tod, Michel...
British Journal of Cancer. 127 (2022) 1 - p. 79-83 , 2022

Link: https://doi.org/10.1038/..

9

Impact of COVID-19 pandemic on antifungal consumption: a mu..:

Bienvenu, Anne-Lise ; Bestion, Audrey ; Pradat, Pierre...
Critical Care. 26 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

10

Paclitaxel with or without pazopanib for ovarian cancer rel..:

Joly, Florence ; Fabbro, Michel ; Berton, Dominique...
Gynecologic Oncology. 166 (2022) 3 - p. 389-396 , 2022

Link: https://doi.org/10.1016/..

11

Covariate analysis of tusamitamab ravtansine, a DM4 anti‐CE..:

Pouzin, Clemence ; Tod, Michel ; Chadjaa, Mustapha..
CPT: Pharmacometrics & Systems Pharmacology. 11 (2022) 3 - p. 384-394 , 2022

Link: https://doi.org/10.1002/..

12

Quantitative Prediction of Adverse Event Probability Due to..:

Tod, Michel ; Rodier, Thomas ; Auffret, Marine
Drug Safety. 45 (2022) 7 - p. 755-764 , 2022

Link: https://doi.org/10.1007/..

13

Population Pharmacokinetics and Dosing Simulation of Vancom..:

Garreau, Romain ; Falquet, Benoît ; Mioux, Lisa...
Antibiotics. 10 (2021) 10 - p. 1228 , 2021

Link: https://doi.org/10.3390/..

14

Modeling Approach to Predict the Impact of Inflammation on ..:

Simon, Florian ; Gautier-Veyret, Elodie ; Truffot, Aurélie...
Pharmaceutical Research. 38 (2021) 3 - p. 415-428 , 2021

Link: https://doi.org/10.1007/..

15

Does DDI-Predictor Help Pharmacists to Detect Drug-Drug Int..:

Moreau, Fanny ; Simon, Nicolas ; Walther, Julia...
Metabolites. 11 (2021) 3 - p. 173 , 2021

Link: https://doi.org/10.3390/..